Nutex Health (NUTX) EPS (Basic) (2010 - 2026)

Nutex Health has disclosed EPS (Basic) across 17 years of filings, most recently posting $6.7 for Q1 2026.

• EPS (Basic) for Q1 2026 came in at $6.7, up 79.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.52 (down 1.89% YoY), and the FY2025 annual result was $11.13, up 8.8% from the prior year.
• EPS (Basic) came in at $6.7 for Q1 2026 at Nutex Health, up from $1.5 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $11.83 in Q4 2024 to a low of -$7.47 in Q4 2023.
• The 5-year median for EPS (Basic) is -$0.07 (2024), against an average of $1.0.
• Across the five-year window, EPS (Basic) slumped 37250.0% in 2023 and jumped 4775.0% in 2025, its largest moves.
• Nutex Health's EPS (Basic) stood at -$0.02 in 2022, then plunged by 37250.0% to -$7.47 in 2023, then soared by 258.37% to $11.83 in 2024, then slumped by 87.32% to $1.5 in 2025, then soared by 346.67% to $6.7 in 2026.
• The last three EPS (Basic) figures came in at $6.7 (Q1 2026), $1.5 (Q4 2025), and $8.27 (Q3 2025), per Business Quant data.